Risk factors for biopsy‐proven advanced non‐alcoholic fatty liver disease in the Veterans Health Administration
Alimentary Pharmacology & Therapeutics2017Vol. 47(2), pp. 268–278
Citations Over TimeTop 10% of 2017 papers
Yuval A. Patel, Elizabeth J. Gifford, Lisa Glass, Rebecca B. McNeil, Michael J. Turner, Byungjoo Han, Dawn Provenzale, Steven S. Choi, Cynthia A. Moylan, Christine M. Hunt
Abstract
In the VHA, diabetes and severe obesity increased risk for advanced fibrosis in NAFLD. Of these patients, only a small proportion (~20%) had enrolled in diet/exercise programs or had bariatric surgery (~2%). These results suggest that providers should focus/tailor interventions to improve outcomes, particularly in those with diabetes and severe obesity.
Related Papers
- → Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease(2008)250 cited
- → Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?(2012)215 cited
- → Are Steatosis and Steatohepatitis Triggers of Hepatic Fibrogenesis(2013)2 cited
- → Faculty Opinions recommendation of Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis.(2008)
- → STUDY OF CELL MODELS OF HEPG2 STEATOSIS AND STEATOHEPATITIS VIABILITY(2023)